Did Pfizer Blink And What Will Pharma Do Now?

Pfizer confirmed that time has run out for raising prices without blow-back. The renewed attention to drug price hikes means business as usual has ended and two questions loom large for Pharma. Is talk of regulation of drug prices next and who will next gain attention because of Pfizer and why?

Read the full post on Forbes - Healthcare